Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Sarcoma × Sunitinib × Clear all

Phase

Phase 2 4 Phase 1/2 2 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Renal Cell 14 Neoplasms 11 Kidney Neoplasms 5 Stomach Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Breast Neoplasms 4 Solid Tumors 3 Prostatic Neoplasms 3 Pancreatic Neoplasms 3 Neoplasm Metastasis 3 Glioblastoma 3 Gastrointestinal Stromal Tumors 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Leukemia, Myeloid, Acute 2 Glioma 2 Colorectal Neoplasms 2 Clear-cell metastatic renal cell carcinoma 2 Adenoma, Islet Cell 2 Uveal Melanoma 1 Urologic Neoplasms 1 Urologic Diseases 1 Urogenital Neoplasms 1 Unspecified Adult Solid Tumor, Protocol Specific 1 Tongue Neoplasms 1 Thrombocytosis 1 Thoracic Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma 1 Salivary Gland Neoplasms 1 Primary Myelofibrosis 1

Interventions

Doxorubicin 23 Cyclophosphamide 23 Gemcitabine 14 Radiotherapy 11 Filgrastim 11 pazopanib 10 Cisplatin 9 pembrolizumab 8 Docetaxel 8 Radiation 7 Ifosfamide 7 Granulocyte Colony-Stimulating Factor 7 Busulfan 7 fludarabine 6 Trabectedin 6 Peripheral Blood Stem Cell Transplantation 6 Mesna 6 Melphalan 6 Ipilimumab 6 Etoposide 6 Carboplatin 6 Bevacizumab 6 selinexor 5 olaratumab 4 aflibercept 4 Topotecan 4 Thiotepa 4 Temozolomide 4 Nivolumab 4 Methotrexate 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01498835 2017-08-28

SunRaSe

Heidelberg University

Phase 1 Completed

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡